Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

2781-2790 of 4090 results

Catalogue Number:

PX-TA1671

Category:

G

Proteo Genix logo

Gomiliximab Biosimilar – Anti-FCER2 mAb – Research Grade

Target: FCER2
Target Alias Name: Gomiliximab/GOMILIXIMAB/ LUMILIXIMAB/ IDEC-152/ PRIMATIZED ANTI-CD23/ ST-152/ IMMUNOGLOBULIN G1/ ANTI-(HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN)/ DISULFIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN/ DIMER/FCER2/anti-FCER2
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1405

Category:

G

Proteo Genix logo

Gontivimab Biosimilar – Anti-RSV glycoprotein F mAb – Research Grade

Target: RSV glycoprotein F
Target Alias Name: Gontivimab /ALX-0171/VR-465/RSV glycoprotein F/anti-RSV glycoprotein F
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: VH-VH-VH
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1936

Category:

G

Proteo Genix logo

Gorivitug Biosimilar – Anti-SARS-CoV-2 RBD mAb – Research Grade

Target: SARS-CoV-2 RBD
Target Alias Name: anti-SARS-CoV-2 RBD
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1528

Category:

G

Proteo Genix logo

Gosuranemab Biosimilar – Anti-MAPT mAb – Research Grade

Target: MAPT
Target Alias Name: Gosuranemab/BMS-986168/IPN-002/huIPN-002/MAPT/anti-MAPT
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1949

Category:

G

Proteo Genix logo

Gotistobart Biosimilar – Anti-CD152 mAb – Research Grade

Target: CD152
Target Alias Name: anti-CD152/ Cytotoxic T-lymphocyte protein 4/ CTLA-4/ CTLA4/ Cytotoxic T-lymphocyte-associated antigen 4
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1591

Category:

G

Proteo Genix logo

Gremubamab Biosimilar – Anti-PcrV mAb – Research Grade

Target: PcrV
Target Alias Name: Gremubamab /MEDI3902/PcrV/anti-PcrV
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: VH-CH1-VH-V-KAPPA-CH2-CH3
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1758

Category:

G

Proteo Genix logo

Gresonitamab Biosimilar – Anti-CLDN18 & CD3e mAb – Research Grade

Target: CLDN18 & CD3e
Target Alias Name: Gresonitamab/AMG 910/ AMG-910/ AMG910/CLDN18 & CD3e/anti-CLDN18 & CD3e
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: (scFv-heavy-kappa)-(scFv-heavy-lambda)-scFc
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1672

Category:

G

Proteo Genix logo

Grisnilimab Biosimilar – Anti-CD7 mAb – Research Grade

Target: CD7
Target Alias Name: Grisnilimab/GRISNILIMAB/IMMUNOGLOBULIN G2A-LAMBDA/ ANTI-(CD7 (CD7 ANTIGEN (P41)/GP40/ LEU-9/ TP41/ TP40))/ MUS MUSCULUSMONOCLONAL ANTIBOD (GRISNILIMAB)/ IMMUNOGLOBULIN G2A/ ANTI-(HUMAN CD7 ANTIGEN) (MUS MUSCULUS MONOCLONAL WT1 .GAMMA.2A-CHAIN)/ DISULFIDE WITH MUS MUSCULUS MONOCLONAL WT1 .LAMBDA.-CHAIN/ DIMER/CD7/anti-CD7
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2a/Lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA2121

Category:

G

Proteo Genix logo

Gruticibart Biosimilar – Anti-Plasma thromboplastin antecedent mAb – Research Grade

Target: Plasma thromboplastin antecedent
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1767

Category:

G

Proteo Genix logo

Gumokimab Biosimilar – Anti-IL17 mAb – Research Grade

Target: IL17
Target Alias Name: Gumokimab/AK 111/ AK-111/ AK111/IL17/anti-IL17
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo